Filter
201
Filtered Results: 201
Text search:
teste
genotípico
Featured
Recommendations
28
New Publications
52
Language
Document type
No document type
108
Guidelines
43
Studies & Reports
29
Manuals
10
Strategic & Response Plan
8
Training Material
2
Fact sheets
1
Countries / Regions
Western and Central Europe
10
India
9
Eastern Europe
7
Colombia
6
Ethiopia
5
Global
4
Africa
4
Venezuela
3
Latin America and the Carribbean
3
Myanmar / Burma
3
Kenya
2
Estonia
2
Malawi
2
Mozambique
2
Asia
2
Paraguay
2
Argentina
2
Bangladesh
2
South Africa
2
Zambia
2
North Macedonia
1
Thailand
1
Lesotho
1
Benin
1
Sierra Leone
1
Chile
1
Nigeria
1
Senegal
1
Philippines
1
USA
1
Tanzania
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Uruguay
1
Bolivia
1
Uganda
1
Russia
1
Romania
1
Georgia
1
Botswana
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
58
Clinical Guidelines
38
Public Health
9
Pharmacy & Technologies
8
Capacity Building
1
Women & Child Health
1
Key Resources
1
Toolboxes
TB
72
HIV
30
AMR
19
NTDs
9
Mental Health
7
Rapid Response
6
Refugee
2
COVID-19
2
Pharmacy
2
NCDs
2
Polio
2
Natural Hazards
1
Ebola & Marburg
1
Caregiver
1
Planetary Health
1
A medida que el tratamiento antirretrovírico con dolutegravir se extiende a más personas que viven con el VIH en el
mundo, adquiere más importancia estimar la frecuencia con que surge la farmacorresistencia adquirida a este
antirretrovírico en las poblaciones tratadas con esquemas que lo conti...
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
Unofficial Translation
Approved by the Federal Government on October 20, 2016
The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and co...
6th edition
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
A survey of prevention, testing and treatment policies and practices
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
Disease Control Division, Standard Management Guideline;Directorate General of Health Services, Ministry of Health & Family Welfare: First Published: 15th May 2017
interim guidance, 25 November 2024
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Prepared as an outcome of ICMR Expert Group on Immunophenotyping of Hematolymphoid Neoplasms | Coordinated by Division of Non Communicable Diseases | This document addresses on various issue related to good quality practices in laboratory work up of flow cytometric immunophenotyping and will be of u...
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care...
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
